349 related articles for article (PubMed ID: 23974972)
1. [The significance of early diagnosis of cancer-related hypercalcaemia].
Radványi I; Csikós A; Balogh S
Orv Hetil; 2013 Sep; 154(35):1367-73. PubMed ID: 23974972
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and management of cancer associated hypercalcaemia.
Ralston SH
Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
[TBL] [Abstract][Full Text] [Related]
3. The management of hypercalcaemia in advanced cancer.
Pettifer A; Grant S
Int J Palliat Nurs; 2013 Jul; 19(7):327-31. PubMed ID: 24273809
[TBL] [Abstract][Full Text] [Related]
4. Modern management of malignant hypercalcemia.
Legrand SB
Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
[TBL] [Abstract][Full Text] [Related]
5. [Hypercalcemia in myeloma].
Abe M
Nihon Rinsho; 2007 Dec; 65(12):2245-9. PubMed ID: 18069268
[TBL] [Abstract][Full Text] [Related]
6. Managing hypercalcaemia and hypocalcaemia in cancer patients.
Fallah-Rad N; Morton AR
Curr Opin Support Palliat Care; 2013 Sep; 7(3):265-71. PubMed ID: 23912385
[TBL] [Abstract][Full Text] [Related]
7. Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders.
Sargent JT; Smith OP
Br J Haematol; 2010 May; 149(4):465-77. PubMed ID: 20377591
[TBL] [Abstract][Full Text] [Related]
8. Immobilisation hypercalcaemia.
Mifsud S; Mifsud EL; Agius SM; Mula A; Gruppetta M
Br J Hosp Med (Lond); 2022 Jun; 83(6):1-7. PubMed ID: 35787163
[TBL] [Abstract][Full Text] [Related]
9. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
Weissglas M; Löwik C; Schamhart D; Theuns H; Kurth KH; Papapoulos S
BJU Int; 2007 Jun; 99(6):1530-3. PubMed ID: 17428243
[TBL] [Abstract][Full Text] [Related]
10. [Hypercalcemia (with treatment)].
Prié D
Rev Prat; 2006 Oct; 56(16):1827-33. PubMed ID: 17315511
[No Abstract] [Full Text] [Related]
11. [Treatment of hypercalcaemia].
Andersen TS; Vestergaard P
Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096564
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypercalcaemia of malignancy in adults.
Mc Donald D; Drake MT; Crowley RK
Clin Med (Lond); 2023 Sep; 23(5):503-507. PubMed ID: 37775175
[TBL] [Abstract][Full Text] [Related]
13. Cancer-related hypercalcemia and potential treatments.
Almuradova E; Cicin I
Front Endocrinol (Lausanne); 2023; 14():1039490. PubMed ID: 37033238
[TBL] [Abstract][Full Text] [Related]
14. Cancer-induced hypercalcemia.
Lumachi F; Brunello A; Roma A; Basso U
Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365
[TBL] [Abstract][Full Text] [Related]
15. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH; Dalkin AC
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
[TBL] [Abstract][Full Text] [Related]
16. Malignancy associated hypercalcaemia-responsiveness to IV bisphosphonates and prognosis in a palliative population.
Mallik S; Mallik G; Macabulos ST; Dorigo A
Support Care Cancer; 2016 Apr; 24(4):1771-7. PubMed ID: 26441077
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and treatment of hypercalcemia of malignancy.
Clines GA
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
[TBL] [Abstract][Full Text] [Related]
18. Current management of malignant hypercalcaemia.
Stevenson JC
Drugs; 1988 Aug; 36(2):229-38. PubMed ID: 3053127
[TBL] [Abstract][Full Text] [Related]
19. [Tumoral hypercalcemia: physiopathology and treatment].
Rizzoli R; Jung A; Bonjour JP
Schweiz Med Wochenschr; 1985 Mar; 115(10):326-32. PubMed ID: 3157214
[TBL] [Abstract][Full Text] [Related]
20. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
